Active components Sofosbuvir and Ledipasvir belong to the category of antiviral medicines used for the treatment of chronic viral hepatitis C.
Pharmaceutical companies located in the United States, Gilead Sciences, Inc. produce the original antiviral medicine containing the drug Ladipasvir and Sofosbuvir. In addition, Indian medicines manufacturers are involved in the serial production of licensed generics such as MyHep-LVIR and other.

Daclatasvir is a powerful and effective medicinal product for fighting the hepatitis C virus of all genotype. This drug is produced under the brand names DaciHep - Marketed by Zydus Heptiza, available in tablets of 60 mg. On the drug market, Daclatasvir is available under different brands name such as - Natdac, DaclaHep, MyHep and others.